These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1802946)

  • 1. A histopathological and immunological profile of a single lesion lepromatous leprosy (LLs).
    Misra RS; Ravi S; Iyengar B; Nath I
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):645-8. PubMed ID: 1802946
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of lepromin reactivity in cured lepromatous leprosy patients: impaired chemokine response dissociates protective immunity from delayed type hypersensitivity.
    Mitra DK; Joshi B; Dinda AK; Rai AK; Girdhar BK; Katoch K; Bindra MS; Sengupta U
    Microbes Infect; 2009 Dec; 11(14-15):1122-30. PubMed ID: 19703581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of rIL-2 in the modulation of cellular immunity in resistance to infection.
    Kaplan G
    Behring Inst Mitt; 1991 Feb; (88):228-9. PubMed ID: 2049043
    [No Abstract]   [Full Text] [Related]  

  • 4. Disturbance of the blood T:B lymphocyte ratio in lepromatous leprosy. Clinical and immunologic correlations.
    Dwyer JM; Bullock WE; Fields JP
    N Engl J Med; 1973 May; 288(20):1036-9. PubMed ID: 4540496
    [No Abstract]   [Full Text] [Related]  

  • 5. Single lesion borderline lepromatous leprosy.
    Ranjan Kar B; Belliappa PR; Ebenezer G; Job CK
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):45-7. PubMed ID: 15217316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculoid relapse in lepromatous leprosy.
    Waters MF; Ridley DS
    Lepr Rev; 1990 Dec; 61(4):353-65. PubMed ID: 2280657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs.
    Foss NT; Pagnano PM; Bechelli LM; Lima Filho EC
    Acta Leprol; 1991; 7(4):335-45. PubMed ID: 1950443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological profile of treated lepromatous leprosy patients.
    Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic responses in patients with lepromatous leprosy.
    Rea TH; Quismorio FP; Harding B; Nies KM; Di Saia PJ; Levan NE; Friou GJ
    Arch Dermatol; 1976 Jun; 112(6):791-800. PubMed ID: 1085131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T and B lymphocytes and blastogenesis in leprosy.
    Sharma S; Ganguly NK; Kumar B; Kaur S; Chakravarty RN
    Lepr India; 1979 Apr; 51(2):194-202. PubMed ID: 314551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte blastogenesis and lepromin reactivity in leprosy patients and their parents.
    Foss NT; Pagnano PM; Bechelli LM; Simoes AL
    Acta Leprol; 1990; 7(2):119-28. PubMed ID: 2220296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on T cell subsets and functions in leprosy.
    Bach MA; Chatenoud L; Wallach D; Phan Dinh Tuy F; Cottenot F
    Clin Exp Immunol; 1981 Jun; 44(3):491-500. PubMed ID: 6459897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
    Silva C; Lima AO; Andrade LM; Mattos O
    Clin Exp Immunol; 1973 Sep; 15(1):87-92. PubMed ID: 4765722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment on immune responsiveness in lepromatous leprosy patients.
    Esquenazi DA; Sampaio EP; Moreira AL; Gallo ME; Almeida SM; Sarno EN
    Lepr Rev; 1990 Sep; 61(3):251-7. PubMed ID: 2215058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic evidence to show that indeterminate leprosy may be a primary lesion of the disease.
    Job CK; Baskaran B; Jayakumar J; Aschhoff M
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):443-9. PubMed ID: 9465152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
    Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
    Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment: Positive Mitsuda lepromin reaction in long-term treated lepromatous leprosy and tuberculoid relapse in lepromatous leprosy.
    Walter J
    Lepr Rev; 1991 Dec; 62(4):434-6. PubMed ID: 1845302
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of epidermal cell proliferation in skin lesions in lepromatous leprosy is greater than in indeterminate and tuberculoid leprosy lesions.
    Palermo MH; Vugman I; Fleury RN; Zucoloto S
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):37-43. PubMed ID: 8627111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
    Kar BR; Job CK
    Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.